197 related articles for article (PubMed ID: 30307312)
1. Inhaled combination of sildenafil and rosiglitazone improves pulmonary hemodynamics, cardiac function, and arterial remodeling.
Rashid J; Nozik-Grayck E; McMurtry IF; Stenmark KR; Ahsan F
Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L119-L130. PubMed ID: 30307312
[TBL] [Abstract][Full Text] [Related]
2. Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency.
Gupta N; Rashid J; Nozik-Grayck E; McMurtry IF; Stenmark KR; Ahsan F
Mol Pharm; 2017 Mar; 14(3):830-841. PubMed ID: 28165252
[TBL] [Abstract][Full Text] [Related]
3. Treprostinil palmitil inhibits the hemodynamic and histopathological changes in the pulmonary vasculature and heart in an animal model of pulmonary arterial hypertension.
Corboz MR; Plaunt AJ; Malinin V; Li Z; Gauani H; Chun D; Cipolla D; Perkins WR; Chapman RW
Eur J Pharmacol; 2022 Feb; 916():174484. PubMed ID: 34508752
[TBL] [Abstract][Full Text] [Related]
4. Inhaled PLGA particles of prostaglandin E₁ ameliorate symptoms and progression of pulmonary hypertension at a reduced dosing frequency.
Gupta V; Gupta N; Shaik IH; Mehvar R; Nozik-Grayck E; McMurtry IF; Oka M; Komatsu M; Ahsan F
Mol Pharm; 2013 May; 10(5):1655-67. PubMed ID: 23485062
[TBL] [Abstract][Full Text] [Related]
5. Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH).
Rashid J; Patel B; Nozik-Grayck E; McMurtry IF; Stenmark KR; Ahsan F
J Control Release; 2017 Mar; 250():96-106. PubMed ID: 28185800
[TBL] [Abstract][Full Text] [Related]
6. Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH.
Rashid J; Alobaida A; Al-Hilal TA; Hammouda S; McMurtry IF; Nozik-Grayck E; Stenmark KR; Ahsan F
J Control Release; 2018 Jun; 280():113-123. PubMed ID: 29723610
[TBL] [Abstract][Full Text] [Related]
7. NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension.
Mulvaney EP; Reid HM; Bialesova L; Bouchard A; Salvail D; Kinsella BT
BMC Pulm Med; 2020 Apr; 20(1):85. PubMed ID: 32252727
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
[TBL] [Abstract][Full Text] [Related]
9. Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension.
Tang Y; Tan S; Li M; Tang Y; Xu X; Zhang Q; Fu Q; Tang M; He J; Zhang Y; Zheng Z; Peng J; Zhu T; Xie W
BMC Pulm Med; 2022 Apr; 22(1):142. PubMed ID: 35413880
[TBL] [Abstract][Full Text] [Related]
10. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
Mouchaers KT; Schalij I; de Boer MA; Postmus PE; van Hinsbergh VW; van Nieuw Amerongen GP; Vonk Noordegraaf A; van der Laarse WJ
Eur Respir J; 2010 Oct; 36(4):800-7. PubMed ID: 20351034
[TBL] [Abstract][Full Text] [Related]
11. Sildenafil protects against pulmonary hypertension induced by hypoxia in neonatal rats via activation of PPARγ‑mediated downregulation of TRPC.
Huang W; Liu N; Tong X; Du Y
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34935055
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary hemodynamic responses to brain natriuretic peptide and sildenafil in patients with pulmonary arterial hypertension.
Klinger JR; Thaker S; Houtchens J; Preston IR; Hill NS; Farber HW
Chest; 2006 Feb; 129(2):417-425. PubMed ID: 16478861
[TBL] [Abstract][Full Text] [Related]
13. The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats.
Lang M; Kojonazarov B; Tian X; Kalymbetov A; Weissmann N; Grimminger F; Kretschmer A; Stasch JP; Seeger W; Ghofrani HA; Schermuly RT
PLoS One; 2012; 7(8):e43433. PubMed ID: 22912874
[TBL] [Abstract][Full Text] [Related]
14. Targeted Delivery of Sildenafil for Inhibiting Pulmonary Vascular Remodeling.
Li B; He W; Ye L; Zhu Y; Tian Y; Chen L; Yang J; Miao M; Shi Y; Azevedo HS; Ma Z; Hao K
Hypertension; 2019 Mar; 73(3):703-711. PubMed ID: 30636546
[TBL] [Abstract][Full Text] [Related]
15. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
Shi R; Wei Z; Zhu D; Fu N; Wang C; Yin S; Liang Y; Xing J; Wang X; Wang Y
Pulm Pharmacol Ther; 2018 Feb; 48():124-135. PubMed ID: 29133079
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.
Ghofrani HA; Wiedemann R; Rose F; Olschewski H; Schermuly RT; Weissmann N; Seeger W; Grimminger F
Ann Intern Med; 2002 Apr; 136(7):515-22. PubMed ID: 11926786
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide.
Lepore JJ; Maroo A; Bigatello LM; Dec GW; Zapol WM; Bloch KD; Semigran MJ
Chest; 2005 May; 127(5):1647-53. PubMed ID: 15888841
[TBL] [Abstract][Full Text] [Related]
18. Effects of Single Drug and Combined Short-term Administration of Sildenafil, Pimobendan, and Nicorandil on Right Ventricular Function in Rats With Monocrotaline-induced Pulmonary Hypertension.
Nakata TM; Tanaka R; Yoshiyuki R; Fukayama T; Goya S; Fukushima R
J Cardiovasc Pharmacol; 2015 Jun; 65(6):640-8. PubMed ID: 25806612
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension.
Voswinckel R; Reichenberger F; Enke B; Kreckel A; Krick S; Gall H; Schermuly RT; Grimminger F; Rubin LJ; Olschewski H; Seeger W; Ghofrani HA
Pulm Pharmacol Ther; 2008 Oct; 21(5):824-32. PubMed ID: 18657627
[TBL] [Abstract][Full Text] [Related]
20.
Peng Y; Dai J; Zhao YY
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
